Cargando…

Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression

To understand how neural-immune-associated genes and pathways contribute to neurodegenerative disease pathophysiology, we performed a systematic functional genomic analysis in purified microglia and bulk tissue from mouse and human AD, FTD, and PSP. We uncover a complex temporal trajectory of microg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rexach, Jessica E., Polioudakis, Damon, Yin, Anna, Swarup, Vivek, Chang, Timothy S., Nguyen, Tam, Sarkar, Arjun, Chen, Lawrence, Huang, Jerry, Lin, Li-Chun, Seeley, William, Trojanowski, John Q., Malhotra, Dheeraj, Geschwind, Daniel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842189/ https://www.ncbi.nlm.nih.gov/pubmed/33207193 http://dx.doi.org/10.1016/j.celrep.2020.108398

Ejemplares similares

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.
por: Swarup, Vivek, et al.
Publicado: (2018)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

MiR-191 Regulates Primary Human Fibroblast Proliferation and Directly Targets Multiple Oncogenes
por: Polioudakis, Damon, et al.
Publicado: (2015)

miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing
por: Polioudakis, Damon, et al.
Publicado: (2015)

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
por: Henderson, Michael X., et al.
Publicado: (2019)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019)

Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
por: Blennow, Kaj, et al.
Publicado: (2019)

Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
por: Swarup, Vivek, et al.
Publicado: (2020)

LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons
por: Henderson, Michael X., et al.
Publicado: (2021)

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
por: Soares, Alberto Carpinteiro, et al.
Publicado: (2021)

Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer’s Disease and Related Dementias
por: Hromadkova, Lenka, et al.
Publicado: (2022)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
por: Gibbons, Garrett S., et al.
Publicado: (2020)

Astroglial tau pathology alone preferentially concentrates at sulcal depths in chronic traumatic encephalopathy neuropathologic change
por: Arena, John D, et al.
Publicado: (2020)

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
por: Marshall, Courtney A., et al.
Publicado: (2022)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability
por: Silva, M. Catarina, et al.
Publicado: (2016)

Young‐onset frontotemporal dementia in a homozygous tau R406W mutation carrier
por: Ng, Adeline S. L., et al.
Publicado: (2015)

Noradrenaline drives immunosuppression in sepsis: clinical consequences
por: Stolk, Roeland F., et al.
Publicado: (2020)

Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018)

An intrinsically disordered protein, osteopontin, driving neuropathology in Alzheimer’s dementia
por: Steinman, Lawrence
Publicado: (2023)

TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading
por: Martini-Stoica, Heidi, et al.
Publicado: (2018)

Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
por: Sánchez, Marina P., et al.
Publicado: (2018)

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
por: Kühn, Rebekka, et al.
Publicado: (2021)

Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP
por: Olm, Christopher A., et al.
Publicado: (2022)

Driving and Patients With Dementia
por: Hamdy, R. C., et al.
Publicado: (2018)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
por: Uemura, Maiko T., et al.
Publicado: (2020)

(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019)

Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
por: Ruhland, Megan K., et al.
Publicado: (2016)

Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy
por: Rangel, Roberto, et al.
Publicado: (2022)

Tumors recycle glucocorticoids to drive Treg-mediated immunosuppression
por: Swatler, Julian, et al.
Publicado: (2023)

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
por: Sankaranarayanan, Sethu, et al.
Publicado: (2015)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Tyrosine phosphatase STEP(61) in human dementia and in animal models with amyloid and tau pathology
por: Taylor, Deonne, et al.
Publicado: (2023)

Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration
por: Taylor, Laura M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p0jrjq2c9t4igk9jds892jac47